Myasthenia Gravis Treatment Klygefa Wins FDA Approval as a Weekly C5 Inhibitor Shot Adults Inject at Home
The FDA approved Klygefa, a weekly self-injected C5 inhibitor for adults with acetylcholine receptor antibody-positive generalized myasthenia gravis, based on results from the PREVAIL trial.
Medical Daily ·